Skip to main content

Blogs Guest Blog

Jason Shafrin, PhD, FTI Consulting
Guest Blog
08/26/2021
Jason Shafrin, PhD; Jason Shafrin, PhD
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
Guest Blog
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
Guest Blog
02/18/2021
Leo P. Langlois, MD, PT
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
05/08/2020
Gordon Kuntz
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
07/11/2019
Marsha K. Millonig, MBA, BPharm
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
07/03/2019
Adil Akhtar, MD
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
01/07/2019
Kandace Schuft, PharmD
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
12/14/2018
Thomas Goetz, MPH
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
05/07/2018
Sowmya Josyula, MD, MPH; Bobby Daly, MD, MBA
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
04/28/2018
Tim Holder, MD
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways